Aijun Chao

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Incidence and risk factors of medical complications and direct medical costs after osteoporotic fracture among patients in China

Ruiqi Liu, Aijun Chao, Ke Wang et al. · Archives of Osteoporosis · 2018 · 42 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Effects of Jintiange on the healing of osteoporotic fractures in aged rats

Jie Liu, Tingting Liu, Haicheng Zhang et al. · Journal of Orthopaedic Surgery and Research · 2024 · 27 citations · Full text

Medicine, Surgery, Aging +15

Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study

Mei Li, Zhenlin Zhang, Qingyun Xue et al. · Archives of Osteoporosis · 2022 · 26 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +14

A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk

Hao Zhang, Jie‐Mei Gu, Aijun Chao et al. · Acta Pharmacologica Sinica · 2022 · 24 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16